Latest Breaking News On - Dose escalation study - Page 1 : comparemela.com

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 - Jasper Therapeutics (NASDAQ:JSPR)

REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting

United statesLauren walkerAlex grayJoyce allaireEdwin tuckerEuropean academy of allergyJasper therapeutics incSingle subcutaneous sc administration to healthyEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicineChief medical officerDose escalation study

HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, Companies B

HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, Companies B
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesLas vegasInhibitor key companiesClinical successJanssen pharmaceuticalsRoute of administrationXynomic pharmaceuticals incInhibitor route of administrationXynomic pharmaceuticalsUniversity collaborations licensing partnering analysisInhibitor companiesEpigen pharmaceuticalsClinical trialsPipeline insightSample reportPipeline analysis

Jasper Therapeutics to Present Data on Briquilimab in Mast

Jasper Therapeutics to Present Data on Briquilimab in Mast
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAlex grayJoyce allaireEdwin tuckerLauren walkerEuropean academy of allergySingle subcutaneous sc administration to healthyJasper therapeutics incEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicineChief medical officerDose escalation study

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren walkerEdwin tuckerAlex grayJoyce allaireSingle subcutaneous sc administration to healthyEuropean academy of allergyJasper therapeutics incPresent dataMast cell driven diseasesEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicine

Coherus Presents Preliminary Results from Phase I Dose

CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective.

United statesMccormick placeRosh diasJodi sieversCoherus biosciencesJami taylorCorporate communicationsAbbvie incExchange commissionExchange commission onAmgen incCoherus biosciences incCoheru chief medicalPreliminary resultsDose escalation studyAdvanced solid